TailorMed and RxSense have partnered to integrate manufacturer copay assistance programmes into digital pharmacy marketplaces. The collaboration embeds TailorMed's affordability technology into RxSense-powered marketplace tools, allowing retail pharmacies to display manufacturer copay and foundation assistance programmes alongside cash-pay coupons. The integration covers over 2,200 brand-name medications, including Eliquis, Dupixent, Keytruda, Ozempic, and Zepbound. With one in three Americans unaware that drug manufacturer financial assistance programmes exist, the partnership addresses a gap for individuals searching for prescription savings. The combined offering enables pharmacy staff to connect customers with assistance programmes when they are actively searching for affordable medication options. TailorMed operates a medication success platform whilst RxSense provides pharmacy benefit solutions.

RxUtility and RxSense Partner to simplify access to prescription savings. NASHVILLE, TN, UNITED STATES, May 20, 2026 / EINPresswire.com / - RxUtility, the real-time medication affordability platform, and RxSense, a healthcare technology company delivering pharmacy benefit solutions that improve affordability and access, today announced a new partnership to help patients more easily find and access the lowest available price for their medications. Savings opportunities exist across insurance, cash pay, manufacturer programs, and discount cards, but they are fragmented, difficult to access, and rarely visible in one place. According to the Kaiser Family Foundation, 6 in 10 U.S. adults are concerned about affording their prescription medications, and demand for pricing transparency continues to grow. "People assume they're seeing the best price for their medication. Most of the time, they're not," said Miriam Paramore, Founder and CEO of RxUtility. "Savings are scattered across different programs, and they're not designed to show up when people actually need them. This partnership brings those options together in one place, so people can make a clear, informed choice. RxSense expands the depth of options in our platform, and together we share a mission to improve choice, transparency, and control for people." Through this partnership, RxSense will bring a scalable, API-driven platform that enables real-time access to prescription pricing and savings through a single integration, allowing RxUtility to incorporate pricing and pharmacy networks from RxSense's proprietary discount card brands, including SingleCare and Paramount Rx, into its workflows. Together, the companies deliver a more unified solution that improves price transparency and expands access to savings, making it easier for people to choose the lowest-cost option within a single workflow. For RxUtility, RxSense fills a key gap: a network layer that expands reach across payers, employers, and pharmacy partners. "Patients deserve to know they're getting the best price on their prescriptions, every time," said John Zevzavadjian, President of Enterprise and Partner Solutions at RxSense. "By combining RxUtility's workflow with RxSense's pricing infrastructure and savings networks, we're making that a reality. This partnership closes the gap between what patients pay and what they could pay, and that's exactly the kind of progress we're here to drive." About RxUtility RxUtility provides AI-native technology purpose-built to make medications affordable for consumers. RxUtility is the only company to connect providers, pharmacists, employers, payers and digital health partners with real-time access to all medication prices through its affordability platform. By embedding prescription affordability and transparency in these tech workflows, RxUtility reduces patient payment confusion, drives medication adherence and ensures equitable access to prescription drugs. Learn more at www.rxutility.com. About RxSense RxSense is a healthcare technology company delivering industry-leading pharmacy benefit solutions that help organizations improve affordability and access to prescription medications. Built on a modern, cloud-native platform, RxSense offers real-time claims adjudication, advanced analytics, and configurable tools that adapt to the needs of a dynamic healthcare landscape. RxSense is also the parent company of SingleCare and Paramount Rx, trusted brands that extend RxSense's mission of making medications more affordable and accessible to consumers nationwide. Headquartered in Boston, RxSense is committed to empowering its partners with smarter technology and consumer-centric models that drive better outcomes across the pharmacy benefit ecosystem. For more information, visit www.rxsense.com. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Healthcareindustrytoday do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Blue Genes has partnered with RxSense to integrate pharmacogenomics insights into pharmacy benefit workflows at the point of claims adjudication. The collaboration will embed Blue Genes' precision medicine capabilities into RxSense's enterprise pharmacy technology platform, enabling real-time genetic insights to inform medication selection. The solution aims to help pharmacy benefit managers and plan sponsors reduce trial-and-error prescribing, minimise adverse drug reactions, and improve cost efficiency by identifying optimal medications and dosages before costly inefficiencies occur. By integrating pharmacogenomic data directly into adjudication workflows, the partnership seeks to transform genetic insights from siloed information into actionable decision-support tools. Blue Genes focuses on advancing pharmacogenomics to optimise medication outcomes, whilst RxSense provides pharmacy benefits solutions to healthcare organisations.